Investor News Archives - Page 2 of 2

Inify Laboratories – extra bolagsstämma 2022-05-09

Investor News, News 2022-05-09

STOCKHOLM – 9 maj 2022 Inify Laboratories har hållit en extra bolagsstämma den 9 maj 2022. Bifogat finns en sammanfattning av de beslut som fattades vid den extra bolagsstämman. Vänligen kontakta: för frågor angående den extra stämman. Nedladdningar Sammanfattning Extra bolagsstämma 2022-05-09 (pdf)

Inify Laboratories – kallelse till extra bolagsstämma

Investor News, News, Uncategorized 2022-04-11

STOCKHOLM – 11 april 2022 Inify Laboratories bjuder härmed in sina aktieägare till en extra bolagsstämma den 9 maj 2022. Bifogat finns kallelse inklusive dagordning och information om hur man registrerar sig och röstar. Vänligen kontakta: för frågor angående den extra stämman. Nedladdningar Kallelse extra bolagsstämma (pdf) Anmälningsblankett bolagsstämma (pdf) Styrelsens redogörelse enligt 13 […]

INIFY Laboratories AB becomes an independent company

Home, Investor News, News 2021-12-10

STOCKHOLM – December 10, 2021 – ContextVision, a medical technology software company specializing in image processing, today announces that at the EGM of ContextVision on Dec 10th, it was resolved that the subsidiary INIFY Laboratories will become an independent company through a distribution of its shares to existing shareholders of ContextVision. The company will build […]

ContextVision to focus pathology efforts on the establishment of a fully AI-supported lab service

Home, Investor News, News 2021-11-15

ContextVision today announces that the Board of Directors of ContextVision has decided to make a strategic shift and focus its pathology business unit entirely on the establishment of an AI based pathology lab service.

ContextVision – Aiming to build the company’s first modern pathology lab

Financial reports, Home, Investor News, News 2021-10-21

ContextVision has decided to build its first fully digital pathology laboratory – thus confirming its strong dedication to advancing digitalization within pathology, for the best of both patients and the medical profession.